Europe Approves Abbott CGM Device; FDA Review Underway

The FDA is currently reviewing a continuous glucose monitoring system from Abbott, the “FreeStyle Navigator.” The CGM device, if approved, will join the CGM systems currently offered by Medtronic and Dexcom.

Abbott’s system has already received the European CE (Conformité Européenne) mark of approval, which allows the company to market the device in Europe.

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.